CA2171972A1 - Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds - Google Patents

Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds

Info

Publication number
CA2171972A1
CA2171972A1 CA002171972A CA2171972A CA2171972A1 CA 2171972 A1 CA2171972 A1 CA 2171972A1 CA 002171972 A CA002171972 A CA 002171972A CA 2171972 A CA2171972 A CA 2171972A CA 2171972 A1 CA2171972 A1 CA 2171972A1
Authority
CA
Canada
Prior art keywords
heteroarylsulfonamido
heteroarylamino
substituted
benzylaminomethyl
piperidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002171972A
Other languages
French (fr)
Other versions
CA2171972C (en
Inventor
Harry R. Howard, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Harry R. Howard, Jr.
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/122,306 external-priority patent/US5502932A/en
Application filed by Harry R. Howard, Jr., Pfizer Inc. filed Critical Harry R. Howard, Jr.
Priority claimed from PCT/IB1994/000221 external-priority patent/WO1995007908A1/en
Publication of CA2171972A1 publication Critical patent/CA2171972A1/en
Application granted granted Critical
Publication of CA2171972C publication Critical patent/CA2171972C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention relates to novel heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethylpiperidines and, specifically, to compounds of formula ()7, wherein W, Rt, R3, P and A are as defined in the specification, and to intermediates used in the synthesis of such compounds. The novel compounds of formula (n are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
CA002171972A 1993-09-17 1994-07-18 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds Expired - Fee Related CA2171972C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/122,306 US5502932A (en) 1992-02-05 1993-09-17 Method and device of earthquake resistant & energy reduction for high-rise structures
US08/123,306 1993-09-17
PCT/IB1994/000221 WO1995007908A1 (en) 1993-09-17 1994-07-18 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds

Publications (2)

Publication Number Publication Date
CA2171972A1 true CA2171972A1 (en) 1995-03-23
CA2171972C CA2171972C (en) 2001-07-24

Family

ID=22401931

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002171972A Expired - Fee Related CA2171972C (en) 1993-09-17 1994-07-18 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds

Country Status (1)

Country Link
CA (1) CA2171972C (en)

Also Published As

Publication number Publication date
CA2171972C (en) 2001-07-24

Similar Documents

Publication Publication Date Title
CA2157117A1 (en) Spirocyclic Piperidine Derivatives
CA2141048A1 (en) Substituted benzylamino nitrogen containing non-aromatic heterocycles
CA2134964A1 (en) Bridged Aza-Bicyclic Derivatives as Substance P Antagonists
WO1993000330A3 (en) Azanorbornane derivatives
CA2150123A1 (en) Aminomethylene substituted non-aromatic heterocycles
CA2152486A1 (en) Anticonvulsant sorbopyranose sulfamates
CA2223094A1 (en) Phenylpyridazinones
BG103485A (en) Ketobanzamides as calpain inhibitors
DE69615682D1 (en) N- (1-ALKYL-5-PHENYL-2,3,4,5-TETRAHYDRO-1-H-BENZO [B] [1,5] -DIAZEPIN-3-YL) -ACETAMIDE
CA2114727A1 (en) Quinoline Derivatives as Immunostimulants
CA2124083A1 (en) Preparation of substituted piperidines
CA2188580A1 (en) N-cyanoaryl nitrogen heterocycles
CA2080249A1 (en) Preparation of substituted piperidines
PL336640A1 (en) Substituted 3,3-diamino-2- propenonitriles, their production and application
YU12000A (en) Substituted 1,2,3,4,,5,6,-hexahydro-2,6-methano-3- benzazocine-10-oles, method for the production and use thereof as medicaments
CA2227762A1 (en) Substituted aminouracils
CA2007261A1 (en) Novel tetralin derivatives
CA2258539A1 (en) Ring-fused dihydropyranes, process for the preparation and use thereof
CA2171972A1 (en) Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds
DE69533214D1 (en) 2,3-Dihydro-1H-isoindole derivatives, process for their preparation and their use as inhibitors of serotonin reuptake
CA2352893A1 (en) Substituted 1,3,5-triazines
FI962322A (en) Crystalline, polymorphic form of (S, S, S) -N- (1- (2-carboxy-3- (N2-mesyllysylamino) propyl) -1-cyclopentylcarbonyl tyrosine
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
CA2284646A1 (en) Synthesis of intermediates useful in preparing tricyclic compounds
ES2087813A1 (en) Non-aromatic heterocycles containing substituted benzylamine nitrogen

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed